P Veronesi Selected Research

ViFuP protocol

10/2003	Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.
11/2001	Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Veronesi Research Topics

Disease

42	Breast Neoplasms (Breast Cancer) 12/2022 - 08/2000
23	Neoplasms (Cancer) 12/2022 - 08/2000
7	Neoplasm Metastasis (Metastasis) 12/2022 - 11/2001
5	Carcinoma (Carcinomatosis) 09/2009 - 07/2001
2	Carcinogenesis 12/2022 - 06/2002
2	Residual Neoplasm 02/2015 - 12/2003
2	Male Breast Neoplasms (Male Breast Cancer) 12/2007 - 06/2002
1	Surgical Wound 12/2018
1	Hemangiosarcoma (Angiosarcoma) 05/2015
1	Necrosis 02/2012
1	Infections 09/2009
1	Lymphatic Metastasis 03/2007
1	Contracture 01/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2005
1	Calcinosis 12/2005
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2003
1	Fistula 01/2003
1	Postmenopausal Osteoporosis 09/2001

Drug/Important Bio-Agent (IBA)

9	Estrogen ReceptorsIBA 03/2014 - 08/2000
8	Progesterone Receptors (Progesterone Receptor)IBA 03/2013 - 08/2000
7	Biological ProductsIBA 02/2015 - 02/2002
5	Phenobarbital (Luminal)FDA Link 03/2014 - 10/2010
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2004
2	Hormones (Hormone)IBA 12/2022 - 08/2000
2	human ERBB2 proteinIBA 02/2012 - 10/2010
2	Letrozole (Femara)FDA LinkGeneric 09/2007 - 09/2006
2	AnthracyclinesIBA 09/2006 - 11/2001
2	Vinorelbine (Navelbine)FDA LinkGeneric 10/2003 - 11/2001
2	Cisplatin (Platino)FDA LinkGeneric 10/2003 - 11/2001
2	Fluorouracil (Carac)FDA LinkGeneric 10/2003 - 11/2001
1	AntimetabolitesIBA 12/2022
1	Serine (L-Serine)FDA Link 12/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2022
1	Methotrexate (Mexate)FDA LinkGeneric 12/2022
1	CarbonIBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 12/2017
1	PlasticsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	C-Reactive ProteinIBA 03/2014
1	Sex Hormone-Binding GlobulinIBA 03/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2014
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2007
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2006
1	Triptorelin Pamoate (Trelstar)FDA Link 09/2006
1	Taxoids (Taxanes)IBA 09/2006
1	Docetaxel (Taxotere)FDA Link 09/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2006
1	Cyclin-Dependent Kinase Inhibitor p27IBA 06/2002
1	Raloxifene Hydrochloride (Evista)FDA Link 09/2001
1	Indicators and Reagents (Reagents)IBA 03/2001
1	Estrogens (Estrogen)FDA Link 08/2000

Therapy/Procedure

10	Therapeutics 12/2022 - 09/2001
10	Drug Therapy (Chemotherapy) 12/2022 - 08/2000
9	Radiotherapy 07/2021 - 07/2001
7	Mastectomy (Mammectomy) 12/2018 - 10/2003
6	Segmental Mastectomy (Lumpectomy) 11/2019 - 07/2001
2	Mammaplasty (Breast Reconstruction) 01/2020 - 06/2013
2	Conservative Treatment 03/2009 - 01/2006
2	ViFuP protocol 10/2003 - 11/2001
1	Maintenance Chemotherapy 12/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2021
1	Neoadjuvant Therapy 02/2015
1	Role Playing (Playing, Role) 06/2013
1	Prophylactic Mastectomy 02/2012
1	Prostheses and Implants (Prosthesis) 09/2009
1	Combined Modality Therapy 06/2008
1	Contraindications 12/2007
1	Breast Implants (Breast Implant) 01/2006
1	Pancreatectomy 01/2003
1	Pancreaticojejunostomy 01/2003
1	Aftercare (After-Treatment) 09/2001